CardioFocus, a Marlborough, Massachusetts-based medical device company developing technology to treat cardiac disorders, has received a $5m in debt financing from Silicon Valley Bank.
CardioFocus intends to use the funds to initiate its pivotal trial in the United States and to expand the commercialization of its products in Europe.
Led by President and CEO Stephen W. Sagon, the company focuses on improving treatments for patients suffering from atrial fibrillation. Through its Endoscopic Ablation System, CardioFocus allows physicians to visualize complex cardiac anatomy in living color and perform a transcatheter procedure
The company recently raised $30.6m in equity funding.